Inactive Instrument

ALPA HEAL

Equities

ALPA

US02073F1049

Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023

August 15, 2023 at 02:53 am IST

Alpha Healthcare Acquisition Corp. III reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net income was USD 0.317511 million compared to net loss of USD 0.346986 million a year ago.
For the six months, net income was USD 0.893578 million compared to net loss of USD 0.874516 million a year ago.

Latest news about ALPA HEAL

Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Alpha Healthcare Acquisition Corp. III(NasdaqCM:ALPA) dropped from NASDAQ Composite Index	17/23/17	CI
Alpha Healthcare Acquisition Completes Combination With Carmell Therapeutics	15/23/15	MT
Carmell Therapeutics Corporation completed the acquisition of Alpha Healthcare Acquisition Corp. III from a group of shareholders in a reverse merger transaction.	14/23/14	CI
Alpha Healthcare Acquisition Executes Non-Binding Letter of Intent to Acquire Regenerative Medicine Company	27/23/27	MT
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16	CI
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Full Year Ended December 31, 2022	18/23/18	CI
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Full Year Ended December 31, 2022	18/23/18	CI
Alpha Healthcare Acquisition Corp. III Auditor Raises 'Going Concern' Doubt	17/23/17	CI
Alpha Healthcare Acquisition Corp. III to Merge With Carmell Therapeutics	05/23/05	MT
Alpha Healthcare Acquisition Corp. III executed a definitive business combination agreement to acquire Alpha Healthcare Acquisition Corp. III from a group of shareholders for approximately $150 million in a reverse merger transaction.	04/23/04	CI
Alpha Healthcare Acquisition Corp. III executed a definitive business combination agreement to acquire Carmell Therapeutics Corporation for approximately $150 million.	04/23/04	CI
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/22/11	CI
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2022	21/22/21	CI
Alpha Healthcare Acquisition Corp. III Reports Earnings Results for the Eleven Months Ended December 31, 2021	16/22/16	CI
Alpha Healthcare Acquisition Corp. III Auditor Raises 'Going Concern' Doubt	15/22/15	CI
Certain Class B Common Stock of Alpha Healthcare Acquisition Corp. III are subject to a Lock-Up Agreement Ending on 24-JAN-2022.	24/22/24	CI
Alpha Healthcare Acquisition Corp. III(NasdaqCM:ALPA) added to NASDAQ Composite Index	23/21/23	CI
Alpha Healthcare Acquisition Corp. III has completed an IPO in the amount of $150 million.	26/21/26	CI
Alpha Healthcare Acquisition Corp. III has filed an IPO in the amount of $150 million.	04/21/04	CI

Chart ALPA HEAL

Duration

Period

More charts

Company Profile

Alpha Healthcare Acquisition Corp. III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has not selected any specific business combination target and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company intend to focus on the healthcare industry. The Company has not conducted any operations and has not generated any revenues.

Sector

More about the company